30 research outputs found
Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy
BACKGROUND AND OBJECTIVE: T cell-mediated immunity plays an important role in enhancing antitumor response.This study aimed to investigate the changes in the T-lymphocyte subpopulation and to characterize the differential expression pattern of corresponding regulatory genes in peripheral blood mononuclear cells (PBMCs) from diffuse large B cell lymphoma (DLBCL) patients before and after chemotherapy. METHODS: A total of 56 DLBCL patients were recruited for analysis of T-cell subset distribution in the peripheral blood using flow cytometry; serum interferon (IFN)-Ī³ and interleukin (IL)-4 levels using enzyme-linked immunosorbent assays; and early growth response protein 1 (EGR-1), T-bet, GATA-binding protein 3 (GATA-3), and transforming growth factor (TGF)-Ī² mRNA levels using quantitative reverse-transcription polymerase chain reaction. Twenty-six healthy subjects served as controls. RESULTS: The percentage of CD3(+)CD4(+)T lymphocytes in peripheral blood from DLBCL patients was significantly decreased, whereas the percentages of CD3(+)CD8(+)T and CD4(+)CD25(+)T cells were significantly increased compared to those in controls (p < 0.05). Serum levels of IFN-Ī³ and IL-4 were also significantly lower in DLBCL patients than those in controls (p < 0.05), and the levels of EGR-1, T-bet, and GATA-3 mRNA in PBMCs were lower (2.69 Ā± 1.48, 9.43 Ā± 2.14, and 20.83 Ā± 9.05 fold, respectively) in DLBCL patients than those in controls. Furthermore, there was a positive association between the levels of EGR-1 and T-bet mRNA (p = 0.001). However, the level of TGF-Ī² mRNA was significantly increased in DLBCL patients, which was inversely associated with the T-bet mRNA level (p = 0.008), but positively associated with the percentage of T regulatory cells in PBMCs (p = 0.011). After three cycles of chemotherapy, the distribution of T-lymphocyte subsets in DLBCL patients were changed, and the levels of EGR-1, T-bet, and GATA-3 mRNA were significantly increased (p < 0.05) compared to those before chemotherapy. CONCLUSIONS: These results demonstrate the changes in T-lymphocyte subpopulations and the altered expression 34 pattern of the corresponding regulatory genes in PBMCs from DLBCL patients after chemotherapy, which are associated with the response of patients to treatment. The preferential expression of the T-bet gene after chemotherapy was closely correlated with the increased expression of the EGR-1 gene and decreased expression of the TGF-Ī² gene
CXCR5<sup>+</sup> follicular cytotoxic T cells control viral infection in B cell follicles
During unresolved infections, some viruses escape immunological control and establish a persistant reservoir in certain cell types, such as human immunodeficiency virus (HIV), which persists in follicular helper T cells (TFH cells), and Epstein-Barr virus (EBV), which persists in B cells. Here we identified a specialized group of cytotoxic T cells (TC cells) that expressed the chemokine receptor CXCR5, selectively entered B cell follicles and eradicated infected TFH cells and B cells. The differentiation of these cells, which we have called 'follicular cytotoxic T cells' (TFC cells), required the transcription factors Bcl6, E2A and TCF-1 but was inhibited by the transcriptional regulators Blimp1, Id2 and Id3. Blimp1 and E2A directly regulated Cxcr5 expression and, together with Bcl6 and TCF-1, formed a transcriptional circuit that guided TFC cell development. The identification of TFC cells has far-reaching implications for the development of strategies to control infections that target B cells and TFH cells and to treat B cellāderived malignancies
Cell, tissue culture and transformation of Triticum tauschii / by Shoukat Afshar-Sterle.
Bibliography: leaves 83-110.xi, 110, [28] leaves, [20] leaves of plates : ill. (some col.) ; 30 cm.Genetic engineering of Triticum tauschii is an alternative strategy for the genetic improvement of bread wheat...The aim of this project was to develop efficient and reliable protocols for the production of embryogenic callus, suspension and protoplast of Triticum tauschii, and to transform cells by direct uptake of DNA into insertion of DNA using microprojectile bombardment.Thesis (Ph.D.)--University of Adelaide, Dept. of Plant Science, 200
Production of fertile regenerants from protoplasts of Triticum tauschii (Coss.) Schmal.
Four suspension cell lines generated from two accessions of
Triticum tauschii (Coss.) Schmal.
(Aegilops squarrosa, 2n =
2x = 14, DD genome) were used to develop an
efficient protocol for producing fertile regenerants from protoplasts.
Protoplasts were isolated from each cell line by incubating fine cell
aggregates (<500 Āµm in diameter) in a solution containing 3%
Cellulase āOnozukaā RS, 0.5% Macerozyme R10 and 0.2%
Pectolyase Y23. Cell division occurred when the protoplasts were cultured at a
density of 1.0ā1.5 x 106 protoplasts
mLā1 in half-strength MS medium supplemented with
1.1 mg Lā1 2,4-dichlorophenoxyacetic acid (2,4-D),
0.6 M glucose and 1.2% agarose. The first cell divisions were observed
after 5ā7 days. Cell colonies were observed after 14 days and these grew
quickly into large clumps when transferred to half-strength MS medium
supplemented with 2.2 mg L-1 2,4-D, 30 g
Lā1 sucrose and solidified with 0.25%
Phytagel. The colonies produced somatic embryos within 21ā28 days of
transfer to this medium. Somatic embryos were transferred to hormone-free MS
medium for regeneration into plantlets. Although many regenerants produced
shrivelled seeds, 9 of 16 were fertile and produced normal seeds.</jats:p
Establishment of fine suspension cultures of Triticum tauschii ([Coss.]Schmal.) which remain embryogenic for several years
Recommended from our members
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
Although gastric cancer is a leading cause of cancer-related deaths, systemic treatment strategies remain scarce. Here, we report the pro-tumorigenic properties of the crosstalk between intestinal tuft cells and type 2 innate lymphoid cells (ILC2) that is evolutionarily optimized for epithelial remodeling in response to helminth infection. We demonstrate that tuft cell-derived interleukin 25 (IL25) drives ILC2 activation, inducing the release of IL13 and promoting epithelial tuft cell hyperplasia. While the resulting tuft cell - ILC2 feed-forward circuit promotes gastric metaplasia and tumor formation, genetic depletion of tuft cells or ILC2s, or therapeutic targeting of IL13 or IL25 alleviates these pathologies in mice. In gastric cancer patients, tuft cell and ILC2 gene signatures predict worsening survival in intestinal-type gastric cancer where ~40% of the corresponding cancers show enriched co-existence of tuft cells and ILC2s. Our findings suggest a role for ILC2 and tuft cells, along with their associated cytokine IL13 and IL25 as gatekeepers and enablers of metaplastic transformation and gastric tumorigenesis, thereby providing an opportunity to therapeutically inhibit early-stage gastric cancer through repurposing antibody-mediated therapies
Host IL11 Signaling Suppresses CD4 + T cellāMediated Antitumor Responses to Colon Cancer in Mice
International audienceIL11 is a member of the IL6 family of cytokines and signals through its cognate receptor subunits, IL11RA and glycoprotein 130 (GP130), to elicit biological responses via the JAK/STAT signaling pathway. IL11 contributes to cancer progression by promoting the survival and proliferation of cancer cells, but the potential immunomodulatory properties of IL11 signaling during tumor development have thus far remained unexplored. Here, we have characterized a role for IL11 in regulating CD4+ T cell-mediated antitumor responses. Absence of IL11 signaling impaired tumor growth in a sporadic mouse model of colon cancer and syngeneic allograft models of colon cancer. Adoptive bone marrow transfer experiments and in vivo depletion studies demonstrated that the tumor-promoting activity of IL11 was mediated through its suppressive effect on host CD4+ T cells in the tumor microenvironment. Indeed, when compared with Il11ra-proficient CD4+ T cells associated with MC38 tumors, their Il11ra-deficient counterparts displayed elevated expression of mRNA encoding the antitumor mediators IFNĪ³ and TNFĪ±. Likewise, IL11 potently suppressed the production of proinflammatory cytokines (IFNĪ³, TNFĪ±, IL6, and IL12p70) by CD4+ T cells in vitro, which we corroborated by RNAscope analysis of human colorectal cancers, where IL11RAhigh tumors showed less IFNG and CD4 expression than IL11RAlow tumors. Therefore, our results ascribe a tumor cell-extrinsic immunomodulatory role to IL11 during colon cancer development that could be amenable to an anticytokine-based therap
Fas ligandāmediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas
International audienc
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
Abstract Excessive signaling through gp130, the shared receptor for the interleukin (IL)6 family of cytokines, is a common hallmark in solid malignancies and promotes their progression. Here, we established the inĀ vivo utility of bazedoxifene, a steroid analog clinically approved for the treatment of osteoporosis, to suppress gp130ādependent tumor growth of the gastrointestinal epithelium. Bazedoxifene administration reduced gastric tumor burden in gp130Y757F mice, where tumors arise exclusively through excessive gp130/STAT3 signaling in response to the IL6 family cytokine IL11. Likewise, in mouse models of sporadic colon and intestinal cancers, which arise from oncogenic mutations in the tumor suppressor gene Apc and the associated Ī²ācatenin/canonical WNT pathway, bazedoxifene treatment reduces tumor burden. Consistent with the proposed orthogonal tumorāpromoting activity of IL11ādependent gp130/STAT3 signaling, tumors of bazedoxifeneātreated Apcāmutant mice retain excessive nuclear accumulation of Ī²ācatenin and aberrant WNT pathway activation. Likewise, bazedoxifene treatment of human colon cancer cells harboring mutant APC did not reduce aberrant canonical WNT signaling, but suppressed IL11ādependent STAT3 signaling. Our findings provide compelling proof of concept to support the repurposing of bazedoxifene for the treatment of gastrointestinal cancers in which IL11 plays a tumorāpromoting role